These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 20026206)

  • 1. Methionine oxidation stabilizes non-toxic oligomers of alpha-synuclein through strengthening the auto-inhibitory intra-molecular long-range interactions.
    Zhou W; Long C; Reaney SH; Di Monte DA; Fink AL; Uversky VN
    Biochim Biophys Acta; 2010 Mar; 1802(3):322-30. PubMed ID: 20026206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of large oligomers of DOPAL-modified α-synuclein is modulated by the oxidation of methionine residues located at C-terminal domain.
    Coelho-Cerqueira E; de Araújo Correia Campos C; Follmer C
    Biochem Biophys Res Commun; 2019 Feb; 509(2):367-372. PubMed ID: 30591215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine-mediated oxidation of methionine 127 in α-synuclein causes cytotoxicity and oligomerization of α-synuclein.
    Nakaso K; Tajima N; Ito S; Teraoka M; Yamashita A; Horikoshi Y; Kikuchi D; Mochida S; Nakashima K; Matsura T
    PLoS One; 2013; 8(2):e55068. PubMed ID: 23457458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UV-induced selective oxidation of Met5 to Met-sulfoxide leads to the formation of neurotoxic fibril-incompetent α-synuclein oligomers.
    Carmo-Gonçalves P; Pinheiro AS; Romão L; Cortines J; Follmer C
    Amyloid; 2014 Sep; 21(3):163-74. PubMed ID: 24784227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of individual methionines in the fibrillation of methionine-oxidized alpha-synuclein.
    Hokenson MJ; Uversky VN; Goers J; Yamin G; Munishkina LA; Fink AL
    Biochemistry; 2004 Apr; 43(15):4621-33. PubMed ID: 15078109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of dopamine-mediated alpha-synuclein-soluble oligomers requires methionine oxidation.
    Leong SL; Pham CL; Galatis D; Fodero-Tavoletti MT; Perez K; Hill AF; Masters CL; Ali FE; Barnham KJ; Cappai R
    Free Radic Biol Med; 2009 May; 46(10):1328-37. PubMed ID: 19248830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early events in copper-ion catalyzed oxidation of α-synuclein.
    Tiwari MK; Leinisch F; Sahin C; Møller IM; Otzen DE; Davies MJ; Bjerrum MJ
    Free Radic Biol Med; 2018 Jun; 121():38-50. PubMed ID: 29689296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Products of Cu(II)-catalyzed oxidation of the N-terminal fragments of alpha-synuclein in the presence of hydrogen peroxide.
    Kowalik-Jankowska T; Rajewska A; Jankowska E; Wiśniewska K; Grzonka Z
    J Inorg Biochem; 2006 Oct; 100(10):1623-31. PubMed ID: 16839607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The structure of dopamine induced alpha-synuclein oligomers.
    Rekas A; Knott RB; Sokolova A; Barnham KJ; Perez KA; Masters CL; Drew SC; Cappai R; Curtain CC; Pham CL
    Eur Biophys J; 2010 Sep; 39(10):1407-19. PubMed ID: 20309679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methionine oxidation in α-synuclein inhibits its propensity for ordered secondary structure.
    Ponzini E; De Palma A; Cerboni L; Natalello A; Rossi R; Moons R; Konijnenberg A; Narkiewicz J; Legname G; Sobott F; Mauri P; Santambrogio C; Grandori R
    J Biol Chem; 2019 Apr; 294(14):5657-5665. PubMed ID: 30755483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the role of methionine residues on the oligomerization and neurotoxic properties of DOPAL-modified α-synuclein.
    Carmo-Gonçalves P; do Nascimento LA; Cortines JR; Eliezer D; Romão L; Follmer C
    Biochem Biophys Res Commun; 2018 Oct; 505(1):295-301. PubMed ID: 30249394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methionine oxidation, alpha-synuclein and Parkinson's disease.
    Glaser CB; Yamin G; Uversky VN; Fink AL
    Biochim Biophys Acta; 2005 Jan; 1703(2):157-69. PubMed ID: 15680224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The conformation and the aggregation kinetics of α-synuclein depend on the proline residues in its C-terminal region.
    Meuvis J; Gerard M; Desender L; Baekelandt V; Engelborghs Y
    Biochemistry; 2010 Nov; 49(43):9345-52. PubMed ID: 20828147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible inhibition of alpha-synuclein fibrillization by dopaminochrome-mediated conformational alterations.
    Norris EH; Giasson BI; Hodara R; Xu S; Trojanowski JQ; Ischiropoulos H; Lee VM
    J Biol Chem; 2005 Jun; 280(22):21212-9. PubMed ID: 15817478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of cleavage of alpha-synuclein by the 20S proteasome and modulation of its degradation by the RedOx state of the N-terminal methionines.
    Alvarez-Castelao B; Goethals M; Vandekerckhove J; Castaño JG
    Biochim Biophys Acta; 2014 Feb; 1843(2):352-65. PubMed ID: 24315858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. At low concentrations, 3,4-dihydroxyphenylacetic acid (DOPAC) binds non-covalently to alpha-synuclein and prevents its fibrillation.
    Zhou W; Gallagher A; Hong DP; Long C; Fink AL; Uversky VN
    J Mol Biol; 2009 May; 388(3):597-610. PubMed ID: 19328209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular oligomerization of alpha-synuclein is determined by the interaction of oxidized catechols with a C-terminal sequence.
    Mazzulli JR; Armakola M; Dumoulin M; Parastatidis I; Ischiropoulos H
    J Biol Chem; 2007 Oct; 282(43):31621-30. PubMed ID: 17785456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular repair of oxidation-damaged α-synuclein fails to target C-terminal modification sites.
    Binolfi A; Limatola A; Verzini S; Kosten J; Theillet FX; Rose HM; Bekei B; Stuiver M; van Rossum M; Selenko P
    Nat Commun; 2016 Jan; 7():10251. PubMed ID: 26807843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elucidating the Role of Site-Specific Nitration of α-Synuclein in the Pathogenesis of Parkinson's Disease via Protein Semisynthesis and Mutagenesis.
    Burai R; Ait-Bouziad N; Chiki A; Lashuel HA
    J Am Chem Soc; 2015 Apr; 137(15):5041-52. PubMed ID: 25768729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Products of Cu(II)-catalyzed oxidation of alpha-synuclein fragments containing M1-D2 and H50 residues in the presence of hydrogen peroxide.
    Kowalik-Jankowska T; Rajewska A; Jankowska E; Grzonka Z
    Dalton Trans; 2008 Feb; (6):832-8. PubMed ID: 18239841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.